Diabetes CKD — USMLE Step 3 MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Add an SGLT2 inhibitor
SGLT2 inhibitors slow CKD progression and reduce cardiovascular events in diabetes with albuminuric CKD when eGFR permits use.
Reference: ADA Standards of Care in Diabetes—2026; KDIGO Diabetes in CKD Guideline